The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages
Open accessAbstract
// Hideyuki Takahashi 1 , Koichi Sakakura 1 , Takeshi Kudo 1 , Minoru Toyoda 1 , Kyoichi Kaira 2 , Tetsunari Oyama 3 , Kazuaki Chikamatsu 1 1 Department of Otolaryngology-Head and Neck Surgery, Gunma University Graduate School of Medicine, Gunma, Japan 2 Department of Oncology Clinical Development, Gunma University Graduate School of Medicine, Gunma, Japan 3 Department of Pathology, Gunma University Graduate School of Medicine, Gunma, Japan Correspondence to: Kazuaki Chikamatsu, email: tikamatu@gunma-u.ac.jp Keywords: cancer-associated fibroblast (CAF), tumor-associated macrophage (TAM), tumor microenvironment (TME), immunomodulation, immunosuppression Received: August 01, 2016 Accepted: December 07, 2016 Published: December 30, 2016 ABSTRACT Stromal cells in the tumor microenvironment (TME) closely interact with tumor cells and affect tumor cell behavior in diverse manners. We herein investigated the mechanisms by which cancer-associated fibroblasts (CAFs) affect the functional polarization of tumor-associated macrophages (TAMs) in oral squamous cell carcinoma (OSCC) in vitro and in human cancer samples. The expression of CD68, CD14, CD163, CD200R, CD206, HLA-G, CD80, and CD86 was higher in CD14-positive cells co-cultured with the culture supernatants of CAFs established from OSCC specimens (CAF-educated cells) than in control cells. The gene expression level of ARG1 , IL10 , and TGFB1 was increased in CAF-educated cells. CAF-educated cells suppressed T cell proliferation more strongly than control cells, and the neutralization of TGF-β IL-10, or arginase I significantly restored T cell proliferation. We then investigated the relationship between the infiltration of CAFs and TAMs using tissue samples obtained from patients with OSCC. The infiltration of CAFs was associated with the numbers of CD68-positive and CD163-positive macrophages. It also correlated with lymphatic invasion, vascular invasion, lymph node involvement, and the TNM stage. The infiltration of CAFs was identified as an independent prognostic factor in OSCC. Our results indicate that CAFs play important roles in shaping the tumor immunosuppressive microenvironment in OSCC by inducing the protumoral phenotype of TAMs. Therapeutic strategies to reverse CAF-mediated immunosuppression need to be considered.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Martinez, F. O., Gordon, S., Locati, M., & Mantovani, A. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7303 · Cited by 2,125
Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms
Rőszer, T. (2015) · Mediators of Inflammation · doi:10.1155/2015/816460 · Cited by 1,762
Immunosuppressive Strategies that are Mediated by Tumor Cells
Rabinovich, G. A., Gabrilovich, D., & Sotomayor, E. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141609 · Cited by 1,702
Macrophage polarization in tumour progression
Sica, A., Larghi, P., Mancino, A., Rubino, L., Porta, C., Totaro, M. G., Rimoldi, M., Biswas, S. K., Allavena, P., & Mantovani, A. (2008) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2008.03.004 · Cited by 1,241
Immunological hallmarks of stromal cells in the tumour microenvironment
Turley, S. J., Cremasco, V., & Astarita, J. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3902 · Cited by 1,140
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
Role of tissue stroma in cancer cell invasion
De Wever, O., & Mareel, M. (2003) · The Journal of Pathology · doi:10.1002/path.1398 · Cited by 1,042
Boire, A., Covic, L., Agarwal, A., Jacques, S., Sherifi, S., & Kuliopulos, A. (2005) · Cell · doi:10.1016/j.cell.2004.12.018 · Cited by 838
Lyford-Pike, S., Peng, S., Young, G. D., Taube, J. M., Westra, W. H., Akpeng, B., Bruno, T. C., Richmon, J. D., Wang, H., Bishop, J. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2384 · Cited by 777
Gocheva, V., Wang, H.-W., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T., & Joyce, J. A. (2010) · Genes & Development · doi:10.1101/gad.1874010 · Cited by 740
Duluc, D., Delneste, Y., Tan, F., Moles, M.-P., Grimaud, L., Lenoir, J., Preisser, L., Anegon, I., Catala, L., Ifrah, N., et al. (2007) · Blood · doi:10.1182/blood-2007-02-072587 · Cited by 491
WHITESIDE, T. (2006) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.07.008 · Cited by 487
Cancer associated fibroblasts in cancer pathogenesis
Franco, O. E., Shaw, A. K., Strand, D. W., & Hayward, S. W. (2010) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2009.10.010 · Cited by 394
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.
Quatromoni, J. G., & Eruslanov, E. B. (2012) · Europe PMC (PubMed Central) · Cited by 373
Heusinkveld, M., de Vos van Steenwijk, P. J., Goedemans, R., Ramwadhdoebe, T. H., Gorter, A., Welters, M. J. P., van Hall, T., & van der Burg, S. H. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100889 · Cited by 368
Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity
Balsamo, M., Scordamaglia, F., Pietra, G., Manzini, C., Cantoni, C., Boitano, M., Queirolo, P., Vermi, W., Facchetti, F., Moretta, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906481106 · Cited by 330
Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors
Bonde, A.-K., Tischler, V., Kumar, S., Soltermann, A., & Schwendener, R. A. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-35 · Cited by 283
Lewis, M. P., Lygoe, K. A., Nystrom, M. L., Anderson, W. P., Speight, P. M., Marshall, J. F., & Thomas, G. J. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601611 · Cited by 262
Nazareth, M. R., Broderick, L., Simpson-Abelson, M. R., Kelleher, R. J., Yokota, S. J., & Bankert, R. B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.9.5552 · Cited by 259
Macrophage-Derived SPARC Bridges Tumor Cell-Extracellular Matrix Interactions toward Metastasis
Sangaletti, S., Di Carlo, E., Gariboldi, S., Miotti, S., Cappetti, B., Parenza, M., Rumio, C., Brekken, R. A., Chiodoni, C., & Colombo, M. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1327 · Cited by 207
Fujii, N., Shomori, K., Shiomi, T., Nakabayashi, M., Takeda, C., Ryoke, K., & Ito, H. (2012) · Journal of Oral Pathology & Medicine · doi:10.1111/j.1600-0714.2012.01127.x · Cited by 191
Tumor‐stromal crosstalk in invasion of oral squamous cell carcinoma: a pivotal role of CCL7
Jung, D., Che, Z. M., Kim, J., Kim, K., Kim, K., Williams, D., & Kim, J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25060 · Cited by 186
Kaira, K., Sunose, Y., Arakawa, K., Ogawa, T., Sunaga, N., Shimizu, K., Tominaga, H., Oriuchi, N., Itoh, H., Nagamori, S., et al. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.310 · Cited by 177
Self-citationHe, K.-F., Zhang, L., Huang, C.-F., Ma, S.-R., Wang, Y.-F., Wang, W.-M., Zhao, Z.-L., Liu, B., Zhao, Y.-F., Zhang, W.-F., et al. (2014) · BioMed Research International · doi:10.1155/2014/838632 · Cited by 172
Tumour-associated fibroblasts and mesenchymal stem cells: more similarities than differences
Păunescu, V., Bojin, F. M., Tatu, C. A., Gavriliuc, O. I., Rosca, A., Lukinich-Gruia, A. T., Tănasie, G., Bunu, C., Crîsnic, D., Gherghiceanu, M., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01044.x · Cited by 169
Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma
Takahashi, H., Sakakura, K., Kawabata‐Iwakawa, R., Rokudai, S., Toyoda, M., Nishiyama, M., & Chikamatsu, K. (2015) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-015-1742-0 · Cited by 157
Self-citationKellermann, M. G., Sobral, L. M., da Silva, S. D., Zecchin, K. G., Graner, E., Lopes, M. A., Kowalski, L. P., & Coletta, R. D. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.07.001 · Cited by 157
Transforming growth factor-β1 regulates macrophage migration via RhoA
Kim, J.-S., Kim, J.-G., Moon, M.-Y., Jeon, C.-Y., Won, H.-Y., Kim, H.-J., Jeon, Y.-J., Seo, J.-Y., Kim, J.-I., Kim, J., et al. (2006) · Blood · doi:10.1182/blood-2005-10-009191 · Cited by 134
Is the CD200/CD200 Receptor Interaction More Than Just a Myeloid Cell Inhibitory Signal?
Minas, K., & Liversidge, J. (2006) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v26.i3.20 · Cited by 108
Buck, A. C., Schirrmeister, H., Guhlmann, C. A., Diederichs, C. G., Shen, C., Buchmann, I., Kotzerke, J., Birk, D., Mattfeldt, T., & Reske, S. N. (2001) · PubMed · Cited by 89
Kim, J. H., Oh, S.-H., Kim, E. J., Park, S. J., Hong, S. P., Cheon, J. H., Kim, T. I., & Kim, W. H. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.081 · Cited by 88
Dudás, J., Bitsche, M., Schartinger, V. H., Falkeis, C., Sprinzl, G. M., & Riechelmann, H. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2010.11.002 · Cited by 82
Daly, A. J., McIlreavey, L., & Irwin, C. R. (2007) · Oral Oncology · doi:10.1016/j.oraloncology.2007.08.012 · Cited by 79
Tumor-produced, active Interleukin-1 β regulates gene expression in carcinoma-associated fibroblasts
Dudás, J., Fullár, A., Bitsche, M., Schartinger, V. H., Kovalszky, I., Sprinzl, G. M., & Riechelmann, H. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.05.023 · Cited by 66
Byrne, S. N., Knox, M. C., & Halliday, G. M. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100116 · Cited by 62
Leef, G. C., & Thomas, S. M. (2013) · Oral Oncology · doi:10.1016/j.oraloncology.2012.12.014 · Cited by 52
Strnad, H., Lacina, L., Kolář, M., Čada, Z., Vlček, Č., Dvořánková, B., Betka, J., Plzák, J., Chovanec, M., Šáchová, J., et al. (2009) · Histochemistry and Cell Biology · doi:10.1007/s00418-009-0661-6 · Cited by 52
Cited by
Mao, X., Xu, J., Wang, W., Liang, C., Hua, J., Liu, J., Zhang, B., Meng, Q., Yu, X., & Shi, S. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01428-1 · Cited by 2,290
Macrophages and metabolism in the tumor microenvironment
Vitale, I., Manic, G., Coussens, L. M., Kroemer, G., & Galluzzi, L. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.06.001 · Cited by 1,837
Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
Liu, T., Han, C., Wang, S., Fang, P., Ma, Z., Xu, L., & Yin, R. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0770-1 · Cited by 860
Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer
Wu, F., Yang, J., Liu, J., Wang, Y., Mu, J., Zeng, Q., Deng, S., & Zhou, H. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00641-0 · Cited by 773
In search of definitions: Cancer‐associated fibroblasts and their markers
Nurmik, M., Ullmann, P., Rodriguez, F., Haan, S., & Letellier, E. (2020) · International Journal of Cancer · doi:10.1002/ijc.32193 · Cited by 739
Metadata
- Authors
- Takahashi, H., Sakakura, K., Kudo, T., Toyoda, M., Kaira, K., Oyama, T., & Chikamatsu, K.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2016-12-30
- Volume
- 8
- Issue
- 5
- Pages
- 8633-8647
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W2565995236
- Cited by
- 259
- References
- 40
- FWCI
- 8.92
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.